{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:18:13Z","timestamp":1779927493028,"version":"3.53.1"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Melasma is a chronic, relapsing hyperpigmentation disorder with a multifactorial etiology, posing significant treatment challenges. It is associated with substantial psychological and social burdens, often impairing quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>This review comprehensively explores current and emerging laser and light-based treatments for melasma, evaluating their clinical applicability, efficacy, and safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS<\/jats:title>\n                    <jats:p>The National Library of Medicine database (PubMed) was searched for studies published through April 2024. Studies were selected based on relevance to laser and light-based therapies for melasma, including intense pulsed light devices, Q-switched nanosecond lasers, ablative and nonablative fractionated resurfacing lasers, and picosecond lasers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Current treatments such as intense pulsed light and Q-switched nanosecond lasers offer promising results for treatment of melasma but have risks including disease recurrence and postinflammatory pigmentary changes. Emerging treatments such as picosecond lasers show promise in reducing melanin index and improving skin texture with fewer adverse effects, showing significant reductions in melasma area and severity index scores and high patient satisfaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Laser and light-based therapies continue to evolve, with growing support for multimodal approaches that address the complex pathophysiology of melasma. Their advancement provides a nuanced approach to this challenging condition, emphasizing the need for individualized treatment plans and consideration of psychosocial impacts on patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000004878","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T12:04:11Z","timestamp":1759147451000},"page":"355-362","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Laser and Light-Based Therapies for Treating Melasma: An In-Depth Review"],"prefix":"10.1097","volume":"52","author":[{"given":"Zainab","family":"Ridha","sequence":"first","affiliation":[{"name":"Division of Dermatology, McGill University, Montreal, Quebec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payvand","family":"Kamrani","sequence":"additional","affiliation":[{"name":"Cosmetic Laser Dermatology: A Platinum Dermatology Partners Company, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Firsowicz","sequence":"additional","affiliation":[{"name":"Cosmetic Laser Dermatology: A Platinum Dermatology Partners Company, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Zarbafian","sequence":"additional","affiliation":[{"name":"Cosmetic Laser Dermatology: A Platinum Dermatology Partners Company, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavita","family":"Darji","sequence":"additional","affiliation":[{"name":"Cosmetic Laser Dermatology: A Platinum Dermatology Partners Company, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchel P.","family":"Goldman","sequence":"additional","affiliation":[{"name":"Cosmetic Laser Dermatology: A Platinum Dermatology Partners Company, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"R1-20260326","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1590\/abd1806-4841.20143063","article-title":"Melasma: a clinical and epidemiological review","volume":"89","author":"Handel","year":"2014","journal-title":"An Bras Dermatol"},{"key":"R2-20260326","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archderm.1995.01690240119022","article-title":"Melasma. Etiologic and therapeutic considerations","volume":"131","author":"Grimes","year":"1995","journal-title":"Arch Dermatol"},{"key":"R3-20260326","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1111\/jocd.15242","article-title":"Medical therapies for melasma","volume":"21","author":"Mahajan","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"R4-20260326","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1468-3083.2010.03592.x","article-title":"Aggravating factors for melasma: a prospective study in 197 Tunisian patients","volume":"24","author":"Guinot","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R5-20260326","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1097\/DSS.0000000000002770","article-title":"The vascular component of melasma: a systematic review of laboratory, diagnostic, and therapeutic evidence","volume":"46","author":"Masub","year":"2020","journal-title":"Dermatol Surg"},{"key":"R6-20260326","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jdermsci.2007.01.009","article-title":"The vascular characteristics of melasma","volume":"46","author":"Kim","year":"2007","journal-title":"J Dermatol Sci"},{"key":"R7-20260326","first-page":"169","article-title":"Rationale for the use of topical corticosteroids in melasma","volume":"3","author":"Menter","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"R8-20260326","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.6836297","article-title":"Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation","volume":"220","author":"Anderson","year":"1983","journal-title":"Science"},{"key":"R9-20260326","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5021\/ad.2018.30.1.1","article-title":"Treatment of melasma with pulsed-dye laser and 1,064-nm Q-Switched Nd:YAG laser: a split-face study","volume":"30","author":"Kong","year":"2018","journal-title":"Ann Dermatol"},{"key":"R10-20260326","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1473-2165.2007.00288.x","article-title":"A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma","volume":"6","author":"Ferreira Cestari","year":"2007","journal-title":"J Cosmet Dermatol"},{"key":"R11-20260326","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1111\/jocd.16006","article-title":"Efficacy and safety of laser-related therapy for melasma: a systematic review and network meta-analysis","volume":"22","author":"Ma","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"R12-20260326","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0190-9622(90)70180-P","article-title":"Pulsed dye laser treatment of telangiectases with and without subtherapeutic sclerotherapy. Clinical and histologic examination in the rabbit ear vein model","volume":"23","author":"Goldman","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"R13-20260326","first-page":"1316","article-title":"Treatment of melasma and the use of intense pulsed light: a review","volume":"11","author":"Zaleski","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"R14-20260326","first-page":"693","article-title":"Efficacy and safety of intense pulsed light in treatment of melasma in Chinese patients","volume":"34","author":"Li","year":"2008","journal-title":"Dermatol Surg"},{"key":"R15-20260326","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/14764172.2015.1027228","article-title":"Effectiveness of low-fluence and short-pulse intense pulsed light in the treatment of melasma: a randomized study","volume":"17","author":"Bae","year":"2015","journal-title":"J Cosmet Laser Ther"},{"key":"R16-20260326","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1524-4725.2010.01849.x","article-title":"Sequential treatment with triple combination cream and intense pulsed light is more efficacious than sequential treatment with an inactive (control) cream and intense pulsed light in patients with moderate to severe melasma","volume":"37","author":"Goldman","year":"2011","journal-title":"Dermatol Surg"},{"key":"R17-20260326","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00266-020-01637-x","article-title":"A meta-analysis-based assessment of intense pulsed light for treatment of melasma","volume":"44","author":"Yi","year":"2020","journal-title":"Aesthet Plast Surg"},{"key":"R18-20260326","first-page":"1196","article-title":"Intense pulsed light for the treatment of refractory melasma in Asian persons","volume":"30","author":"Wang","year":"2004","journal-title":"Dermatol Surg"},{"key":"R19-20260326","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1529-8019.2012.01530.x","article-title":"Single-session intense pulsed light combined with stable fixed-dose triple combination topical therapy for the treatment of refractory melasma","volume":"25","author":"Figueiredo Souza","year":"2012","journal-title":"Dermatol Ther"},{"key":"R20-20260326","first-page":"59","article-title":"Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite Laser alone for refractory melasma: split-face design","volume":"29","author":"Angsuwarangsee","year":"2003","journal-title":"Dermatol Surg"},{"key":"R21-20260326","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1524-4725.2011.02018.x","article-title":"Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients","volume":"37","author":"Jang","year":"2011","journal-title":"Dermatol Surg"},{"key":"R22-20260326","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/2047-783X-18-43","article-title":"Treatment of melasma in Caucasian patients using a novel 694-nm Q-switched ruby fractional laser","volume":"18","author":"Hilton","year":"2013","journal-title":"Eur J Med Res"},{"key":"R23-20260326","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1524-4725.1994.tb00152.x","article-title":"Ineffective treatment of refractory melasma and postinflammatory hyperpigmentation by Q-switched ruby laser","volume":"20","author":"Taylor","year":"1994","journal-title":"J Dermatol Surg Oncol"},{"key":"R24-20260326","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/lsm.22263","article-title":"A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma","volume":"46","author":"Fabi","year":"2014","journal-title":"Lasers Surg Med"},{"key":"R25-20260326","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/lsm.23474","article-title":"Treatment of melasma with a low-fluence 1064 nm Q-switched Nd:YAG laser: laser toning in Caucasian women","volume":"54","author":"Micek","year":"2022","journal-title":"Lasers Surg Med"},{"key":"R26-20260326","doi-asserted-by":"crossref","first-page":"jocd.15126","DOI":"10.1111\/jocd.15126","article-title":"Efficacy of low-fluence 1064 nm Q-switched nd: YAG laser for the treatment of melasma: a meta-analysis and systematic review","volume":"21","author":"Chen","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"R27-20260326","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5978\/islsm.12-OR-03","article-title":"Low fluence Q-Switched Nd: YAG laser toning and Q-Switched ruby laser in the treatment of melasma:a comparative split-face ultrastructural study","volume":"21","author":"Omi","year":"2012","journal-title":"Laser Ther"},{"key":"R28-20260326","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/14764172.2016.1262958","article-title":"Comparative study of dual-pulsed 1064 nm Q-switched Nd:YAG laser and single-pulsed 1064 nm Q-switched Nd:YAG laser by using zebrafish model and prospective split-face analysis of facial melasma","volume":"19","author":"Jang","year":"2017","journal-title":"J Cosmet Laser Ther"},{"key":"R29-20260326","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/DSS.0000000000000653","article-title":"Clinical and histopathologic assessment of facial melasma after low-fluence Q-Switched neodymium-doped yttrium aluminium garnet laser","volume":"42","author":"Hofbauer Parra","year":"2016","journal-title":"Dermatol Surg"},{"key":"R30-20260326","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5021\/ad.2012.24.3.267","article-title":"Intense pulsed light and low-fluence Q-Switched Nd:YAG laser treatment in melasma patients","volume":"24","author":"Na","year":"2012","journal-title":"Ann Dermatol"},{"key":"R31-20260326","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/09546634.2011.593487","article-title":"Better clinical results with long term benefits in melasma patients","volume":"24","author":"Na","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"R32-20260326","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1524-4725.2009.01383.x","article-title":"Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians","volume":"36","author":"Wattanakrai","year":"2010","journal-title":"Dermatol Surg"},{"key":"R33-20260326","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/14764172.2014.957217","article-title":"Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy","volume":"17","author":"Choi","year":"2015","journal-title":"J Cosmet Laser Ther"},{"key":"R34-20260326","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/jocd.12444","article-title":"Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: a comparative clinical, histopathological, and immunohistochemical study","volume":"17","author":"Saleh","year":"2018","journal-title":"J Cosmet Dermatol"},{"key":"R35-20260326","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/lsm.20956","article-title":"A case series of facial depigmentation associated with low fluence Q-switched 1,064 nm Nd:YAG laser for skin rejuvenation and melasma","volume":"42","author":"Chan","year":"2010","journal-title":"Lasers Surg Med"},{"key":"R36-20260326","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3390\/medicina58070936","article-title":"The low-fluence Q-Switched Nd:YAG laser treatment for melasma: a systematic review","volume":"58","author":"Lee","year":"2022","journal-title":"Medicina"},{"key":"R37-20260326","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/09546634.2013.848261","article-title":"A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients","volume":"25","author":"Lee","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"R38-20260326","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1365-2230.2011.04150.x","article-title":"A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma","volume":"36","author":"Park","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"R39-20260326","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.sder.2012.02.002","article-title":"The evolution of melasma therapy: targeting melanosomes using low-fluence Q-switched neodymium-doped yttrium aluminium garnet lasers","volume":"31","author":"Kauvar","year":"2012","journal-title":"Semin Cutan Med Surg"},{"key":"R40-20260326","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4103\/0974-2077.104915","article-title":"A comparison of low-fluence 1064-nm Q-switched nd: YAG laser with topical 20% azelaic acid cream and their combination in Melasma in Indian patients","volume":"5","author":"Bansal","year":"2012","journal-title":"J Cutan Aesthet Surg"},{"key":"R41-20260326","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/09546634.2011.646938","article-title":"The degree of erythema in melasma lesion is associated with the severity of disease and the response to the low-fluence Q-switched 1064-nm Nd:YAG laser treatment","volume":"24","author":"Park","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"R42-20260326","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/lsm.20048","article-title":"Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury","volume":"34","author":"Manstein","year":"2004","journal-title":"Lasers Surg Med"},{"key":"R43-20260326","doi-asserted-by":"crossref","first-page":"041115","DOI":"10.1117\/1.2241745","article-title":"Laser-induced transepidermal elimination of dermal content by fractional photothermolysis","volume":"11","author":"Hantash","year":"2006","journal-title":"J Biomed Opt"},{"key":"R44-20260326","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijwd.2017.01.004","article-title":"A review of laser and light therapy in melasma","volume":"3","author":"Trivedi","year":"2017","journal-title":"Int J Women\u2019s Dermatol"},{"key":"R45-20260326","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3109\/09546634.2012.671911","article-title":"Combination of fractional erbium-glass laser and topical therapy in melasma resistant to triple-combination cream","volume":"25","author":"Tourlaki","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"R46-20260326","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1468-3083.2011.04086.x","article-title":"Split-face study of melasma patients treated with non-ablative fractionated photothermolysis (1540 nm)","volume":"26","author":"Barysch","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R47-20260326","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/lsm.20591","article-title":"Histologic and ultrastructural analysis of melasma after fractional resurfacing","volume":"40","author":"Goldberg","year":"2008","journal-title":"Lasers Surg Med"},{"key":"R48-20260326","first-page":"1645","article-title":"The treatment of melasma with fractional photothermolysis: a pilot study","volume":"31","author":"Rokhsar","year":"2005","journal-title":"Dermatol Surg"},{"key":"R49-20260326","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1524-4725.2009.01264.x","article-title":"Treatment of melasma in Asian skin using a fractional 1,550-nm laser: an open clinical study","volume":"35","author":"Lee","year":"2009","journal-title":"Dermatol Surg"},{"key":"R50-20260326","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jaad.2010.01.048","article-title":"Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study","volume":"64","author":"Kroon","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R51-20260326","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/lsm.20937","article-title":"Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study","volume":"42","author":"Wind","year":"2010","journal-title":"Lasers Surg Med"},{"key":"R52-20260326","first-page":"s3","article-title":"The 1440 nm and 1927 nm nonablative fractional diode laser: current trends and future directions","volume":"19","author":"Friedman","year":"2020","journal-title":"J Drugs Dermatol"},{"key":"R53-20260326","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/14764172.2019.1683581","article-title":"Efficacy and safety of 1927 nm fractional thulium fiber laser for the treatment of melasma: a retrospective study of 100 patients","volume":"21","author":"Kurmu\u015f","year":"2019","journal-title":"J Cosmet Laser Ther"},{"key":"R54-20260326","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/jocd.13817","article-title":"Laser-assisted delivery of tranexamic acid for melasma: pilot study using a novel 1927 nm fractional thulium fiber laser","volume":"20","author":"Wang","year":"2021","journal-title":"J Cosmet Dermatol"},{"key":"R55-20260326","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/DSS.0000000000003492","article-title":"1927nm fractional diode laser and oral tranexamic acid for melasma: a 5.7-Year summary on safety and effectiveness","volume":"48","author":"Wang","year":"2022","journal-title":"Dermatol Surg"},{"key":"R56-20260326","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1524-4725.2011.02178.x","article-title":"Treatment of melasma using a novel 1,927-nm fractional thulium fiber laser: a pilot study","volume":"38","author":"Polder","year":"2012","journal-title":"Dermatol Surg"},{"key":"R57-20260326","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/dsu.12176","article-title":"Split-face study using a 1,927-nm thulium fiber fractional laser to treat photoaging and melasma in Asian skin","volume":"39","author":"Lee","year":"2013","journal-title":"Dermatol Surg"},{"key":"R58-20260326","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/lsm.22100","article-title":"Treatment of melasma with the 1,927-nm fractional thulium fiber laser: a retrospective analysis of 20 cases with long-term follow-up","volume":"45","author":"Niwa Massaki","year":"2013","journal-title":"Lasers Surg Med"},{"key":"R59-20260326","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s10103-020-03045-8","article-title":"The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study","volume":"35","author":"Wanitphakdeedecha","year":"2020","journal-title":"Lasers Med Sci"},{"key":"R60-20260326","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1590\/abd1806-4841.20131932","article-title":"The use of the Er:YAG 2940nm laser associated with amorolfine lacquer in the treatment of onychomycosis","volume":"88","author":"Morais","year":"2013","journal-title":"An Bras Dermatol"},{"key":"R61-20260326","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5978\/islsm.14-RE-01","article-title":"The role of the CO2 laser and fractional CO2 laser in dermatology","volume":"23","author":"Omi","year":"2014","journal-title":"Laser Ther"},{"key":"R62-20260326","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10103-024-03972-w","article-title":"Efficacy and safety of ablative fractional laser in melasma: a meta-analysis and systematic review","volume":"39","author":"Zhao","year":"2024","journal-title":"Lasers Med Sci"},{"key":"R63-20260326","first-page":"315","article-title":"The treatment of melasma with topical creams alone, CO2 fractional ablative resurfacing alone, or a combination of the two: a comparative study","volume":"9","author":"Trelles","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"R64-20260326","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3109\/14764172.2010.538412","article-title":"Successful treatment of malar dermal melasma with a fractional ablative CO2 laser in a patient with type V skin","volume":"12","author":"Neeley","year":"2010","journal-title":"J Cosmet Laser Ther"},{"key":"R65-20260326","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/lsm.23032","article-title":"Assessment of combined fractional CO2 and tranexamic acid in melasma treatment","volume":"51","author":"Tawfic","year":"2019","journal-title":"Lasers Surg Med"},{"key":"R66-20260326","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/01913123.2019.1673861","article-title":"Clinical & ultrastructural evaluation of the effect of fractional CO2 laser on facial melasma","volume":"43","author":"El-Sinbawy","year":"2019","journal-title":"Ultrastruct Pathol"},{"key":"R67-20260326","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1524-4725.1999.08103.x","article-title":"Erbium:YAG laser resurfacing for refractory melasma","volume":"25","author":"Manaloto","year":"1999","journal-title":"Dermatol Surg"},{"key":"R68-20260326","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1524-4725.2009.01066.x","article-title":"Treatment of melasma using variable square pulse Er:YAG laser resurfacing","volume":"35","author":"Wanitphakdeedecha","year":"2009","journal-title":"Dermatol Surg"},{"key":"R69-20260326","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1080\/09546634.2021.1968996","article-title":"Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial","volume":"33","author":"Mokhtari","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"R70-20260326","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/14764172.2021.1964536","article-title":"Evaluation of the of the efficacy of fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of kojic acid in the treatment of melasma; a split face, comparative clinical study","volume":"23","author":"Al-Dhalimi","year":"2021","journal-title":"J Cosmet Laser Ther"},{"key":"R71-20260326","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/lsm.23244","article-title":"A systematic review of picosecond laser in dermatology: evidence and recommendations","volume":"53","author":"Wu","year":"2021","journal-title":"Lasers Surg Med"},{"key":"R72-20260326","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10103-023-03744-y","article-title":"Efficacy and safety of picosecond laser for the treatment of melasma: a systematic review and meta-analysis","volume":"38","author":"Feng","year":"2023","journal-title":"Lasers Med Sci"},{"key":"R73-20260326","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/DSS.0000000000003775","article-title":"Efficacy and safety of picosecond laser in the treatment of melasma: a network meta-analysis","volume":"49","author":"Ren","year":"2023","journal-title":"Dermatol Surg"},{"key":"R74-20260326","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/DSS.0000000000003602","article-title":"Prospective study of 532-nm picosecond laser for the treatment of pigmented lesions of the face and dorsal hands","volume":"48","author":"Friedmann","year":"2022","journal-title":"Dermatol Surg"},{"key":"R75-20260326","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/lsm.23261","article-title":"Successful treatment of pigmentary disorders in Asians with a novel 730-nm picosecond laser","volume":"52","author":"Lee","year":"2020","journal-title":"Lasers Surg Med"},{"key":"R76-20260326","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00403-023-02794-0","article-title":"The role of 755-nm alexandrite picosecond laser in melasma management","volume":"316","author":"Pulumati","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"R77-20260326","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1007\/s10103-022-03566-4","article-title":"Efficacy and safety of 755-nm picosecond alexandrite laser with topical tranexamic acid versus laser monotherapy for melasma and facial rejuvenation: a multicenter, randomized, double-blinded, split-face study in Chinese patients","volume":"37","author":"Li","year":"2022","journal-title":"Lasers Med Sci"},{"key":"R78-20260326","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/lsm.23763","article-title":"Comparison of 755-nm picosecond alexandrite laser versus 1064-nm Q-switched Nd:YAG laser for melasma: a randomized, split-face controlled, 2-year follow-up study","volume":"56","author":"Zhou","year":"2024","journal-title":"Lasers Surg Med"},{"key":"R79-20260326","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1007\/s10103-022-03566-4","article-title":"Efficacy and safety of 755-nm picosecond alexandrite laser with topical tranexamic acid versus laser monotherapy for melasma and facial rejuve- nation: a multicenter, randomized, double-blinded, split- face study in Chinese patients","volume":"37","author":"Li","year":"2022","journal-title":"Lasers Med Sci"},{"key":"R80-20260326","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/DSS.0000000000002612","article-title":"Treatment of refractory melasma in Asians with the picosecond alexandrite laser","volume":"46","author":"Polnikorn","year":"2020","journal-title":"Dermatol Surg"},{"key":"R81-20260326","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jdv.15934","article-title":"Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female asian patients with melasma","volume":"34","author":"Wang","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R82-20260326","doi-asserted-by":"crossref","first-page":"1132823","DOI":"10.3389\/fmed.2023.1132823","article-title":"Comparison of the efficacy and safety of picosecond Nd:YAG laser (1,064 nm), picosecond alexandrite laser (755 nm) and 2% hydroquinone cream in the treatment of melasma: a randomized, controlled, assessor-blinded trial","volume":"10","author":"Liang","year":"2023","journal-title":"Front Med"},{"key":"R83-20260326","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/PRS.0000000000009994","article-title":"Comparison of picosecond and nanosecond Nd:YAG 1064-nm lasers in the treatment of melasma: a split-face randomized clinical trial","volume":"151","author":"Feng","year":"2023","journal-title":"Plast Reconstr Surg"},{"key":"R84-20260326","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/lsm.23723","article-title":"Melasma treatment with a 1064 nm, picosecond-domain laser with a fractionated multibeam lens array","volume":"55","author":"Bernstein","year":"2023","journal-title":"Lasers Surg Med"},{"key":"R85-20260326","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/cosmetics11030089","article-title":"Comparing a low-fluence picosecond 1064 nm Nd:YAG laser with a 532 nm Nd:YAG laser for the treatment of pigmented lesions in Chinese patients: a retrospective analysis","volume":"11","author":"Lu","year":"2024","journal-title":"Cosmetics"},{"key":"R87-20260326","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/09546634.2018.1441487","article-title":"Pulsed dye laser versus intense pulsed light in melasma: a split-face comparative study","volume":"29","author":"Hassan","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"R88-20260326","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/lsm.22518","article-title":"Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser","volume":"49","author":"Geddes","year":"2017","journal-title":"Lasers Surg Med"},{"key":"R89-20260326","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1001\/archdermatol.2011.255","article-title":"Melasma treatment with pulsed-dye laser and triple combination cream: a prospective, randomized, single-blind, split-face study","volume":"147","author":"Passeron","year":"2011","journal-title":"Arch Dermatol"},{"key":"R90-20260326","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1016\/j.jaad.2013.02.022","article-title":"Long-lasting effect of vascular targeted therapy of melasma","volume":"69","author":"Passeron","year":"2013","journal-title":"J Am Acad Dermatol"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004878","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:00:43Z","timestamp":1774537243000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004878","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]}}}